BNP/CALL/ALCON AG/80/0.1/20.12.24 Share Price

Warrant

DE000PN7C396

Market Closed - Deutsche Boerse AG 15:21:19 28/05/2024 BST
0.66 EUR -9.59% Intraday chart for BNP/CALL/ALCON AG/80/0.1/20.12.24
Current month+186.96%
1 month+153.85%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
28/05/24 0.66 -9.59%
27/05/24 0.73 +4.29%
24/05/24 0.7 -10.26%
23/05/24 0.78 0.00%
22/05/24 0.78 +23.81%

Delayed Quote Deutsche Boerse AG

Last update May 28, 2024 at 03:21 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ALCON INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN7C39
ISINDE000PN7C396
Date issued 16/08/2023
Strike 80 CHF
Maturity 20/12/2024 (206 Days)
Parity 10 : 1
Emission price 0.47
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.79
Lowest since issue 0.14
Delta0.58x
Omega 7.326
Premium6.84x
Gearing12.65x
Moneyness 1.011
Difference Strike -0.86 CHF
Difference Strike %-1.08%
Spread 0.01
Spread %1.54%
Intrinsic value 0.0868

Company Profile

Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.) At the end of 2023, the group operated 19 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).
Sector
-
More about the company

Ratings for Alcon Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Alcon Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
88.77 USD
Average target price
93.44 USD
Spread / Average Target
+5.26%
Consensus